Veracyte Announces Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Vertiv shares fall on analyst downgrades and options bets
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Stocks edge lower as dollar heads for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
Veracyte (VCYT) Tops Q2 EPS by 2c
July 30, 2020 4:28 PM EDTVeracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $20.6 million.
Second Quarter 2020 Financial Results
For the second quarter of 2020:
Total revenue was $20.7 million, comprising $16.9 million in testing and product revenue and $3.8 million in... More


